Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys
Sarepta Therapeutics said the Duchenne muscular dystrophy patient recently had a cytomegalovirus infection, which can damage the liver and may have contributed to the fatality. It’s the first patient death out of more than 800 patients treated with Elevidys, a gene therapy for the rare muscle-wasting disease. The post Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys appeared first on MedCity News.
Sarepta Therapeutics said the Duchenne muscular dystrophy patient recently had a cytomegalovirus infection, which can damage the liver and may have contributed to the fatality. It’s the first patient death out of more than 800 patients treated with Elevidys, a gene therapy for the rare muscle-wasting disease.
The post Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys appeared first on MedCity News.
